Patient Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108M | Buy |
2,987,988
+15,342
| +0.5% | +$553K | 4.86% | 5 |
|
|
2025
Q1 | $92.5M | Buy |
2,972,646
+97,557
| +3% | +$3.04M | 4.76% | 5 |
|
|
2024
Q4 | $73.3M | Buy |
2,875,089
+833,894
| +41% | +$21.3M | 3.38% | 10 |
|
|
2024
Q3 | $57.7M | Buy |
2,041,195
+616,805
| +43% | +$17.4M | 2.84% | 15 |
|
|
2024
Q2 | $37.6M | Buy |
1,424,390
+4,572
| +0.3% | +$121K | 1.99% | 26 |
|
|
2024
Q1 | $43.1M | Buy |
1,419,818
+165,038
| +13% | +$5.01M | 2.1% | 26 |
|
|
2023
Q4 | $35.2M | Buy |
+1,254,780
| New | +$35.2M | 1.87% | 27 |
|